Navigation Links
Genomic Health Announces Third Quarter 2010 Financial Results and Business Progress
Date:11/8/2010

than 900 sites on four continents in the TAILORx clinical trial.  
  • Signed contracts for payment with several hospitals in the United Kingdom, Ireland and Mexico; and an additional payor in Greece.
  • Presented positive results from first European clinical decision impact study of the Oncotype DX breast cancer test in Spain at the European Society for Medical Oncology (ESMO) Congress, demonstrating a more than 30 percent change in chemotherapy treatment recommendations, consistent with previously reported results in the U.S. and Israel.
  • Presented positive results from an exploratory cost effectiveness analysis of the Oncotype DX breast cancer test in Australia and from a cost-benefit assessment in Singapore at the International Society for Pharmacoeconomics and Outcomes Research (ISPOR) Asia Pacific Conference in September.
  • Presented results at the Inter-American Breast Cancer Conference in July confirming that the distribution of Recurrence Score® results in Latin American breast cancer patients is consistent with those observed in the U.S.
  • Initiated a clinical decision impact study with researchers in Australia.

    • Oncotype DX Colon Cancer Update

  • Secured reimbursement from a leading public insurer in Greece covering more than 20 percent of the population for stage II colon cancer.

    • Product Pipeline, Peer-Reviewed Publications and Medical Meeting Highlights

  • Received acceptance from the Society of Urologic Oncology to present initial results from prostate cancer gene identification study at its upcoming annual meeting on December 9.
  • Initiated sample processing for large clinical trial in ductal carcinoma in situ (DCIS) breast cancer and plan to report results in the first half of 2011.
  • Completed sample processing for a second recurrence study in stage II colon cancer and plan to report results in 2011.
  • The Nationa
    '/>"/>

    • SOURCE Genomic Health, Inc.
    Copyright©2010 PR Newswire.
    All rights reserved

    0

    GOOD

    Page: 1 2 3 4 5 6 7 8

    Related medicine technology :

    1. Harvard Medical School-Partners HealthCare Center for Genetics and Genomics Successfully Completes Evaluation of AutoGenomics 2C9-VKORC1 Panel to Assess Warfarin Sensitivity
    2. Harvard Medical School-Partners HealthCare Center for Genetics and Genomics Successfully Completes Evaluation of AutoGenomics 2C9-VKORC1 Panel to Assess Warfarin Sensitivity
    3. Personalized Medicine - The Genomic Revolution in Cardiac Care
    4. Virogenomics, Inc. Awarded $2 Million National Institute of Standards and Technology (NIST) Advanced Technology Program Grant to Develop Integrated Diagnostic Biosensors
    5. Genomic Health Announces Preliminary Results From a Study of Oncotype DX(TM) in Node-Positive Breast Cancer Patients
    6. Microarray Sequence Capture Speeds Large-Scale Resequencing of Targeted Genomic Regions
    7. BiPar Genomic Biomarker Data Demonstrate Overexpression of PARP-1 Gene in Multiple Cancer Types
    8. Genomic Health Announces Eight Oncotype DX(R) Studies to Be Presented at 30th Annual San Antonio Breast Cancer Symposium
    9. Orion Genomics Announces the Discovery of Novel Breast Cancer Biomarkers
    10. Genomic Health Announces Identification of Genes Associated With Colon Cancer Recurrence Across Multiple Studies
    11. Transgenomic Announces New Contracts for Phase II Trials With Two Major Pharmaceutical Companies
    Post Your Comments:
    *Name:
    *Comment:
    *Email:
    (Date:5/23/2013)... , May 23, 2013   BioLife Solutions ... of proprietary clinical grade hypothermic storage and ... and contract aseptic media manufacturer , today announced ... & Regenerative Medicine Congress 2013 this week in ... http://photos.prnewswire.com/prnh/20090814/BIOLIFELOGO ) Dr. Aby J. Mathew, BioLife,s ...
    (Date:5/23/2013)... SAN DIEGO and PARIS ... VOLC ), a leading developer and manufacturer of ... and treatment of coronary and peripheral vascular disease, today ... V asodilator I ndependent S tenosis ... late breaking clinical trial session at EuroPCR 2013. These ...
    (Date:5/23/2013)... LAUSANNE , Switzerland ... 23, 2013 Cenix BioScience, ... developer specialized in RNAi-, miRNA- and high content-driven ... biopharmaceutical group of companies with a focus on ... medical needs, including oncology and companion diagnostics, today ...
    Breaking Medicine Technology:BioLife Solutions Announces Presentation at 8th World Stem Cells & Regenerative Medicine Congress 2BioLife Solutions Announces Presentation at 8th World Stem Cells & Regenerative Medicine Congress 3Volcano Announces Preliminary Results from the ADVISE II Study and Inclusion in the SYNTAX2 Trial During Hot Line Late Breaking Clinical Trial Sessions at EuroPCR 2013 2Volcano Announces Preliminary Results from the ADVISE II Study and Inclusion in the SYNTAX2 Trial During Hot Line Late Breaking Clinical Trial Sessions at EuroPCR 2013 3Volcano Announces Preliminary Results from the ADVISE II Study and Inclusion in the SYNTAX2 Trial During Hot Line Late Breaking Clinical Trial Sessions at EuroPCR 2013 4Volcano Announces Preliminary Results from the ADVISE II Study and Inclusion in the SYNTAX2 Trial During Hot Line Late Breaking Clinical Trial Sessions at EuroPCR 2013 5Cenix BioScience and Debiopharm Group Collaborate to Identify Predictive Biomarkers 2Cenix BioScience and Debiopharm Group Collaborate to Identify Predictive Biomarkers 3Cenix BioScience and Debiopharm Group Collaborate to Identify Predictive Biomarkers 4
    ... IOMI ) today announced that Stanley C. Erck, the ... Acumen BioFin,Rodman & Renshaw 9th Annual Healthcare Conference in ... will begin at 9:10 a.m. Eastern,Time in the Kennedy ... Mr. Erck,s presentation will focus on Iomai,s portfolio of ...
    ... Exelixis, Inc. (Nasdaq:,EXEL) today presented data from ... with albuminuria due to diabetic nephropathy. XL784 is ... enzymes that may,play a role in the pathogenesis ... presented during a poster session (Abstract/Poster PO1030) at,the ...
    Cached Medicine Technology:Iomai CEO to Speak at Acumen BioFin Rodman & Renshaw Annual Healthcare Conference on Monday, Nov. 5 2Phase 2 Trial Results for Exelixis' XL784 Presented at the 2007 American Society of Nephrology Conference 2Phase 2 Trial Results for Exelixis' XL784 Presented at the 2007 American Society of Nephrology Conference 3Phase 2 Trial Results for Exelixis' XL784 Presented at the 2007 American Society of Nephrology Conference 4
    (Date:5/23/2013)... 23, 2013 Jim Fitzpatrick just did ... Advertising developed yet another outside-of-the-box approach to reaching the ... he brings daily newscasts to the retail automotive industry, ... of a broadcast news format. , CBTNews.com is ... news. Co-anchors Bridget Everett and Russell Brown host the ...
    (Date:5/23/2013)... 23, 2013 To better serve ... company, is pleased to announce the release of ... its pacesetting space division products. Provided by Koroseal, ... the new patterns and colors represent a sophisticated ... meetings with a team of Koroseal experts, Modernfold ...
    (Date:5/23/2013)... now, little was scientifically known about the human potential ... for people who are suffering in a way that ... researchers at the Center for Investigating Healthy Minds at ... that adults can be trained to be more compassionate. ... Psychological Science , is the first to investigate whether ...
    (Date:5/23/2013)... New techniques in imaging of brain activity developed ... Neurological Institute, and his colleagues lead to improved ... combination of electroencephalogram (EEG) and functional magnetic resonance ... the areas generating epileptic seizures, giving neurosurgeons a ... if appropriate. These results were presented at ...
    (Date:5/23/2013)... HealthDay Reporter , , WEDNESDAY, May 22 (HealthDay News) -- Physicians ... lung cancer now have more information to help with the ... that low-dose CT scans pick up significantly more lung tumors ... of smoking are at high risk for lung cancer, the ... have to consider the potential harm of radiation exposure when ...
    Breaking Medicine News(10 mins):Health News:Fitzpatrick Advertising Founder Brings Auto Industry into Focus with CBT News 2Health News:Modernfold Debuts New Colors and Patterns for Space Division Products 2Health News:Study shows people can be trained to be more compassionate 2Health News:Study shows people can be trained to be more compassionate 3Health News:Study shows people can be trained to be more compassionate 4Health News:New imaging techniques used to help patients suffering from epilepsy 2Health News:CT Scans Reduce Lung Cancer Deaths, Study Confirms 2Health News:CT Scans Reduce Lung Cancer Deaths, Study Confirms 3
    ... ... ... ... ...
    ... ... ... ... ...
    ... ... ... ... ...
    ... ... ... ... ...
    ... Two stroke-prevention procedures are safe and equally beneficial for ... effectiveness does vary by age, say researchers at the ... other North American stroke investigators. In findings reported ... Antonio, Texas, the researchers say physicians now have better ...
    ... on routes they knew well , FRIDAY, Feb. 26 ... drivers can make fatal mistakes on familiar routes, German ... brain activity in 16 experienced and 16 less experienced ... the routes on the simulator, the participants, brains were ...
    Cached Medicine News:Health News:Stroke Conference Daily News Summary -- Friday 2Health News:Stroke Conference Daily News Summary -- Friday 3Health News:Stroke Conference Daily News Summary -- Friday 4Health News:Stroke Conference Daily News Summary -- Friday 5Health News:Stroke Conference Daily News Summary -- Friday 6Health News:Aurora BayCare Hosts Statewide Medical Device Business Development Meeting 2Health News:Aurora BayCare Hosts Statewide Medical Device Business Development Meeting 3Health News:Aurora BayCare Hosts Statewide Medical Device Business Development Meeting 4Health News:Aurora BayCare Hosts Statewide Medical Device Business Development Meeting 5Health News:Aurora BayCare Hosts Statewide Medical Device Business Development Meeting 6Health News:Aurora BayCare Hosts Statewide Medical Device Business Development Meeting 7Health News:National Alliance for Hispanic Health Urges Action on Insurance Access as First Step to Achieving Best Health Outcomes for All 2Health News:National Alliance for Hispanic Health Urges Action on Insurance Access as First Step to Achieving Best Health Outcomes for All 3Health News:National Alliance for Hispanic Health Urges Action on Insurance Access as First Step to Achieving Best Health Outcomes for All 4Health News:American National Announces Corrected Dividend Dates 2Health News:Study: Choice between stroke-prevention procedures influenced by patient age 2Health News:Study: Choice between stroke-prevention procedures influenced by patient age 3
    ...
    ...
    The Lineage acetabular system with metal liners uses sophisticated manufacturing methods and materials to minimize wear debris generation....
    The Pivot Bipolar was designed with a simple one-step assembly interface between the femoral head and the compression molded liner which requires no instruments and reduces OR time....
    Medicine Products: